Atrial Fibrillation Device Market - Global Industry Analysis

1
Atrial Fibrillation Market
Opportunities and Forecasts, 2014 2021
Pages 138 Published 2016
2
 
ATRIAL FIBRILLATION MARKET
Catheter ablation would propel the market growth
with a very high rate, as these devices are used
for the treatment of atrial fibrillation when
medications are not effective. Catheter ablation
procedure is very low risk and minimally-invasive
in nature than other surgery (such as MAZE
surgery). Hemali Narkhede
3
 
ATRIAL FIBRILLATION MARKET OVERVIEW

• Atrial Fibrillation Market Report, published by
  Allied Market Research, forecasts that the global
  market is expected to garner 8,319 million by
  2022, registering a CAGR of 13.0 during the
  period 2014 - 2022.
• Non-surgical devices segment dominated the
  overall market in 2015. North America was the
  leading geographic segment in global atrial
  fibrillation devices market in 2015, and is
  expected to maintain its leading position
  throughout forecast period.
• Rise in prevalence rate of atrial fibrillation in
  geriatric population, technological advancements
  in devices, improvement of healthcare
  infrastructure in developing countries,
  development of minimally invasive procedures, and
  increase in patient awareness propel the market
  growth.
• Read more at https//www.alliedmarketresearch.c
  om/atrial-fibrillation-market

4
 
TOP FACTORS IMPACTING GLOBAL ATRIAL FIBRILLATION
MARKET
5
 
ATRIAL FIBRILLATION MARKET KEY BENEFITS

• In-depth analysis of the market is conducted
  based on market estimations of the key segments
  for the period of 2014-2022.
• Comprehensive analysis of factors that drive and
  restrict the growth of the global atrial
  fibrillation market is provided in the report.
• Exhaustive analysis by different segments aids
  tounderstand the different aspects of atrial
  fibrillation that are currently used along with
  the variants that would gain prominence in the
  future.
• Competitive intelligence of leading manufacturers
  and distributors interprets the competitive
  scenario across various geographies.
• Key market players and their strategies are
  analyzed thoroughly, to predict the competitive
  outlook of the global atrial fibrillation market
  share.

6
 
MEXICO ATRIAL FIBRILLATION MARKET (MILLION)
7
 
ATRIAL FIBRILLATION MARKET KEY FINDINGS

• North America dominated the market of atrial
  fibrillation and is expected to maintain its lead
  throughout the forecast period, with a CAGR of
  12.1
• Asia-Pacific is the fastest growing market and is
  estimated to grow at a CAGR of 14.7
• Japan accounted for more than one-third share of
  the Asia-Pacific atrial fibrillation devices
  market in 2015
• The non-surgical equipment segment dominated in
  2015, occupying largest revenue share and is
  anticipated to grow at a CAGR of 12.5
• Catheter ablation (sub segment for surgical
  equipment) accounted for largest market share in
  2015 and is anticipated to grow at a CAGR of
  13.8

8
 
TOP INVESTMENT POCKETS IN GLOBAL ATRIAL
FIBRILLATION MARKET
9
 
KEY PLAYERS IN INDUSTRY

• Abbott Laboratories,
• Johnson Johnson,
• MicroPort Scientific Corporation,
• Boston Scientific Corporation,
• St. Jude Medical, Inc.,
• Medtronic plc,
• Biotronik SE Co. KG,
• Koninklijke Philips N.V.,
• Siemens AG,
• AtriCure Inc.
• Download free Sample Report
• https//www.alliedmarketresearch.com/request-toc/4
  79

10
 
ATRIAL FIBRILLATION MARKET SEGMENTATION
11
 
CATHETER ABLATION MARKET, BY TYPE, 2015
Catheter ablation is the most commonly used
surgical devices for the treatment of cardiac
arrhythmias. It is recommended for the treatment
of AF when anticoagulant drugs and other
medications cannot be administered or tolerated
by the patient. Therefore, this segment accounted
for the major chunk of the overall market in 2015
and is expected to be the fastest-growing market
during the forecast period.
12
 
ATRIAL FIBRILLATION MARKET BY GEOGRAPHY

• North America, Europe, Asia-Pacific, LAMEA

13
 
 
Thank You! For More Details
Visit us at
https//www.alliedmarketresearch.com/atrial-fibril
lation-market
Follow Us On